loading
Schlusskurs vom Vortag:
$1.12
Offen:
$1.1
24-Stunden-Volumen:
52,543
Relative Volume:
2.47
Marktkapitalisierung:
$36.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-3.2462
EPS:
-0.3481
Netto-Cashflow:
-
1W Leistung:
-0.44%
1M Leistung:
-2.51%
6M Leistung:
-15.04%
1J Leistung:
-73.41%
1-Tages-Spanne:
Value
$1.0805
$1.15
1-Wochen-Bereich:
Value
$1.0805
$1.15
52-Wochen-Spanne:
Value
$0.85
$4.34

Akari Therapeutics Plc Adr Stock (AKTX) Company Profile

Name
Firmenname
Akari Therapeutics Plc Adr
Name
Telefon
(646) 350-0702
Name
Adresse
22 BOSTON WHARF ROAD, BOSTON
Name
Mitarbeiter
12
Name
Twitter
@AkariTX
Name
Nächster Verdiensttermin
2024-04-29
Name
Neueste SEC-Einreichungen
Name
AKTX's Discussions on Twitter

Vergleichen Sie AKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.13 36.04M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Akari Therapeutics Plc Adr Stock (AKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-18 Eingeleitet Maxim Group Buy
2019-01-04 Hochstufung B. Riley FBR Neutral → Buy
2018-02-08 Eingeleitet B. Riley FBR, Inc. Neutral
2017-09-22 Hochstufung William Blair Mkt Perform → Outperform
2017-05-31 Hochstufung Chardan Capital Markets Sell → Neutral
2017-04-17 Bestätigt Chardan Capital Markets Sell
2016-07-11 Eingeleitet Chardan Capital Markets Sell
Alle ansehen

Akari Therapeutics Plc Adr Aktie (AKTX) Neueste Nachrichten

pulisher
Jul 23, 2025

Akari Therapeutics advances cancer-fighting ADC technology with PH1 payload - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Revolutionary Cancer Drug PH1 Targets KRAS, BRAF While Activating Immune System Against Tumors - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Akari Therapeutics CEO Shares Exclusive Insights on Next-Gen Cancer Drug Development Strategy - Stock Titan

Jul 22, 2025
pulisher
Jul 11, 2025

INKT Stock Quote Price and Forecast - CNN

Jul 11, 2025
pulisher
Jul 01, 2025

Akari Therapeutics shareholders approve equity plan increase and director elections - Investing.com

Jul 01, 2025
pulisher
Jun 25, 2025

Akari Therapeutics Expands Global IP Portfolio: Key Patent Win for Cancer Drug Platform in India - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

AKTX CEO buys 10,000 ADS at $1.20 in Form 4 insider filing - Stock Titan

Jun 24, 2025
pulisher
Jun 18, 2025

Akari Therapeutics secures Indian patent for cancer drug payload - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Akari's Revolutionary Cancer Drug Technology Wins Key Patent in India's 2.08M Patient Market - Stock Titan

Jun 18, 2025
pulisher
May 22, 2025

Akari Therapeutics CEO Reveals Latest Oncology ADC Developments at Major Webull Investor Event - Stock Titan

May 22, 2025
pulisher
May 17, 2025

Akari Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 17, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business - Investing.com

May 01, 2025
pulisher
Apr 22, 2025

Akari Therapeutics' New CEO Reveals Future Roadmap: Key Insights from First Leadership Address - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Akari Therapeutics Advances ADC Development Amid Financial Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Akari Therapeutics Transforms: Next-Gen Cancer Drug Shows Promise Amid 2024 Results - Stock Titan

Apr 16, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Ibotta Inc (IBTA) Shares Soar Above 1-Year High - The News Heater

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down - Investing.com

Mar 20, 2025
pulisher
Mar 03, 2025

Akari Therapeutics secures $7.6 million in private placement - Investing.com India

Mar 03, 2025
pulisher
Feb 25, 2025

Acciones de Alibaba (BABA) caen tras medidas de Trump para frenar inversiones chinas en tecnología - Yahoo Finanzas

Feb 25, 2025
pulisher
Feb 19, 2025

Citi reveló que Ecopetrol ha publicado la guía de sus resultados para el cuarto trimestre de 2024 - Yahoo Finanzas

Feb 19, 2025
pulisher
Feb 03, 2025

Major ADC Developer Akari Opens Direct Channel to Investors Through Webull Platform - StockTitan

Feb 03, 2025
pulisher
Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024
pulisher
Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024
pulisher
Nov 19, 2024

Akari Therapeutics Regains Nasdaq Compliance, Secures Market Listing Status - StockTitan

Nov 19, 2024
pulisher
Nov 14, 2024

Akari Therapeutics Completes Peak Bio Merger, Secures $53.2M in Financing Commitments - StockTitan

Nov 14, 2024
pulisher
Oct 05, 2024

Akari Therapeutics Plc faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 05, 2024
pulisher
Jun 19, 2024

Riesgos y oportunidades sobre el futuro de la cotización de YPF - Yahoo Finanzas

Jun 19, 2024
pulisher
Jan 23, 2024

¿Qué empresas del Ibex 35 también cotizan fuera de España? - Yahoo Finanzas

Jan 23, 2024
pulisher
Dec 15, 2023

Bancolombia inicia programa para aumentar la liquidez de sus acciones - Yahoo Finanzas

Dec 15, 2023
pulisher
Apr 11, 2023

Akari Therapeutics to Attend ARVO 2023, the Annual Meeting of The Association for Research in Vision and Ophthalmology - StockTitan

Apr 11, 2023
pulisher
Mar 01, 2023

Trending UK-Based Penny Stock Picks 2024 - timothysykes.com

Mar 01, 2023
pulisher
Nov 04, 2022

Peak Bio (PKBO) Stock Price, News & Analysis - MarketBeat

Nov 04, 2022
pulisher
Sep 29, 2022

Las 100 empresas latinoamericanas que se han lanzado a conquistar Wall Street - Yahoo Finanzas

Sep 29, 2022
pulisher
Mar 30, 2022

Tras filtración de datos, las acciones de Globant se hundieron 10% - Yahoo Finanzas

Mar 30, 2022
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021
pulisher
Sep 15, 2020

AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan

Sep 15, 2020
pulisher
Jan 02, 2017

Akari Therapeutics PLC Stock Price Today | NASDAQ: AKTX Live - Investing.com

Jan 02, 2017
pulisher
Aug 18, 2016

Angion Biomedica (ANGN) Stock Price, News & Analysis - MarketBeat

Aug 18, 2016
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011

Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)

Es liegen keine Finanzdaten für Akari Therapeutics Plc Adr (AKTX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):